- Home
- BTOG vs EYEN Comparison
BTOG vs EYEN Comparison
Compare BTOG & EYEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTOG
- EYEN
- Stock Information
- Founded
- BTOG 2018
- EYEN 2014
- Country
- BTOG Singapore
- EYEN United States
- Employees
- BTOG N/A
- EYEN N/A
- Industry
- BTOG Finance: Consumer Services
- EYEN Biotechnology: Pharmaceutical Preparations
- Sector
- BTOG Finance
- EYEN Health Care
- Exchange
- BTOG Nasdaq
- EYEN Nasdaq
- Market Cap
- BTOG 11.0M
- EYEN 9.2M
- IPO Year
- BTOG 2019
- EYEN 2018
- Fundamental
- Price
- BTOG $0.86
- EYEN $0.08
- Analyst Decision
- BTOG
- EYEN Hold
- Analyst Count
- BTOG 0
- EYEN 4
- Target Price
- BTOG N/A
- EYEN $2.00
- AVG Volume (30 Days)
- BTOG 87.6K
- EYEN 19.0M
- Earning Date
- BTOG 01-01-0001
- EYEN 11-12-2024
- Dividend Yield
- BTOG N/A
- EYEN N/A
- EPS Growth
- BTOG N/A
- EYEN N/A
- EPS
- BTOG N/A
- EYEN N/A
- Revenue
- BTOG $7,088,763.00
- EYEN $31,832.00
- Revenue This Year
- BTOG N/A
- EYEN $23,413.60
- Revenue Next Year
- BTOG N/A
- EYEN $400.98
- P/E Ratio
- BTOG N/A
- EYEN N/A
- Revenue Growth
- BTOG 214.61
- EYEN 2557.10
- 52 Week Low
- BTOG $0.81
- EYEN $0.08
- 52 Week High
- BTOG $9.71
- EYEN $2.57
- Technical
- Relative Strength Index (RSI)
- BTOG 25.18
- EYEN 27.49
- Support Level
- BTOG $0.93
- EYEN $0.08
- Resistance Level
- BTOG $1.09
- EYEN $0.09
- Average True Range (ATR)
- BTOG 0.15
- EYEN 0.01
- MACD
- BTOG -0.02
- EYEN 0.01
- Stochastic Oscillator
- BTOG 7.32
- EYEN 13.08
About BTOG Bit Origin Limited
Bit Origin Ltd is seeking opportunities in deploying new technologies, crypto asset mining and blockchain technologies in Singapore. The company has focused on building the Bitcoin mining ecosystem through incubations, strategic investments, and acquisitions.
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.